Smart Pills Technology Market Report 2025 (Global Edition)

Global Smart Pills Technology Market Report 2025 Market Size Split by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), by Target Area (Esophagus, Stomach, Small Intestine, Large Int...

Smart Pills Technology Market Report Description

We have various report editions of Smart Pills Technology Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Smart Pills Technology Market Insights Video

Competitive Landscape of the Smart Pills Technology Market

Numerous major competitors are present in the fiercely competitive global smart pill technology market. These businesses are constantly working on new and cutting-edge technological smart pills through research and development. A few of the industry's leading companies concentrate on new product launches, alliances, joint ventures, and calculated acquisitions in an effort to obtain a competitive advantage. In order to meet the increasing demand for smart pills across a range of healthcare applications, they also make investments in developing their manufacturing capabilities and broadening their networks of distribution. The fierce rivalry in the market propels technical breakthroughs as well as the industry's general expansion and development for smart pills.

March 2024: A digital health startup based in Massachusetts called Celero Systems created a vitamin-sized capsule that had a radio antenna, microprocessors, and tiny sensors. From deep within the gut, it is capable of measuring core temperature, heart rate, and breathing. (Source: https://www.medscape.com/viewarticle/next-gen-smart-pills-will-transform-personalized-care-2024a10004tm#:~:text=Enter%20Celero%20Systems%2C%20a%20Massachusetts,from%20deep%20within%20the%20gut. ) January 2024: The FDA has approved the expanded use of AnX Robotica's NaviCam SB system in adults and children two years of age and older. The NaviCam Tether, an accessory that helps visualize the esophagus prior to swallowing a capsule into the gastrointestinal tract, was also authorized by the FDA. (Source: https://www.medicaldevice-network.com/news/anx-fda-navicam-sb/ ) April 2023: With cutting-edge technology and improvements in surgical techniques, Apollo unveiled the Da Vinci Xi Robotic Surgical System. Compared to open procedures, this technology allows for minimally invasive procedures with tiny incisions, which minimize patient stress, suffering, and recovery time. The Da Vinci Xi system's cutting-edge technology helps to achieve better surgical results. (Source: https://www.fortishealthcare.com/blogs/da-vinci-xi-robotic-surgical-system ) February 2023: AnX Robotica Corp. launched the NaviCam Small Bowel System in the United States of America. The NaviCam SB System, an essential step in the detection of small bowel disease, uses aspherical lens technology to reduce distortion and enhance field of vision. (Source: https://markets.businessinsider.com/news/stocks/anx-robotica-commences-launch-of-the-navicam-small-bowel-system-1032071534 )

Top Companies Market Share in Smart Pills Technology Industry: (In no particular order of Rank)

• Olympus Corporation
• Boston Scientific Corporation
• Medtronic plc
• Philips Healthcare
• Fujifilm Holdings Corporation
• IntroMedic Co.
• Ltd.
• Medisafe
• Proteus Biomedical
• Inc.
• CapsoVision
• Inc.
• MC10 Inc.
• Novartis AG
• GE Healthcare
• Given Imaging Ltd.
• Vitality
• Inc.
• Becton
• Dickinson and Company
• Johnson & Johnson
• Siemens Healthineers
• Pentax Medical
• Microchips Biotech
• Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Smart Pills Technology Market

Which Region Dominates the Smart Pills Technology Market in 2024?

According to Cognitive Market Research, North America currently dominates the Smart Pills Technology market, and the region is expected to have significant growth during the projected period. The area is proud of its well-established healthcare system, cutting-edge medical research facilities, and rapid uptake of cutting-edge medical technology. Moreover, North America is home to a large number of well-known pharmaceutical and medical device businesses, which supports a positive ecosystem for the advancement and monetization of smart pill technologies. North America contributes significantly to the total income generated by the smart pill industry and holds a significant market share in terms of numbers. Smart pill technologies are widely used in clinical settings thanks to the region's strong regulatory environment and the presence of major market participants.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The area is rapidly becoming more urbanized, and the middle class is growing while healthcare costs are rising. This change in the socioeconomic landscape, along with rising knowledge of remote patient monitoring and tailored medication, has made the adoption of smart pills more likely in the area. China and India, two nations with sizable populations and high rates of chronic illness, are becoming major players in the Asia Pacific smart pill industry expansion.

The current report Scope analyzes Smart Pills Technology Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Smart Pills Technology Market Analysis

According to Cognitive Market Research, the global Smart Pills Technology market size was estimated at USD 3654.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1461.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Smart Pills Technology market with a market size of USD 1153.27 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period because of increased rates of cancer, increased use of cutting-edge technologies, and advantageous reimbursement practices.
• The Canada Smart Pills Technology market had a market share of USD 175.40 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period because the healthcare infrastructure in these countries is still emerging and there are insufficient reimbursement mechanisms to provide patients with full coverage.
• The Mexico Smart Pills Technology market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 133.01 million in 2024.

Europe Smart Pills Technology Market Analysis

According to Cognitive Market Research, the global Smart Pills Technology market size was estimated at USD 3654.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1096.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• The United Kingdom Smart Pills Technology market had a market share of USD 184.17 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. This nation will have plenty of room to grow because of the high prevalence of the target diseases and the rising government assistance.
• The France Smart Pills Technology market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 100.86 million in 2024.
• According to Cognitive Market Research, the German Smart Pills Technology market size was valued at USD 217.06 million in 2024 and is projected to grow at a CAGR of 7.7% during the forecast period. The market for smart pill technology is expected to be influenced by the increase in cases of colorectal cancer and the regulatory approval of new products.
• The Italy Smart Pills Technology market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 94.28 million in 2024.
• The Russia Smart Pills Technology market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 169.92 million in 2024.
• The Spain Smart Pills Technology market is projected to witness growth at a CAGR of 6.6% during the forecast period with a market size of USD 89.89 million in 2024
• The Luxembourg Smart Pills Technology market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 33.98 million in 2024.
• The Portugal Smart Pills Technology market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 23.02 million in 2024.
• The Greece Smart Pills Technology market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 13.16 million in 2024.
• The Rest of Europe's Smart Pills Technology market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 169.62 million in 2024.

Asia Pacific Smart Pills Technology Market Analysis

According to Cognitive Market Research, the global Smart Pills Technology market size was estimated at USD 3654.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 840.47 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Smart Pills Technology market size was valued at USD 378.21 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. The market for smart pill technology is expected to grow as gastrointestinal illnesses and stomach cancer become more common.
• The Japan Smart Pills Technology market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 115.98 million in 2024.
• The India Smart Pills Technology market had a market share of USD 100.86 million in 2024 and is projected to grow at a CAGR of 12.8% during the forecast period because of the advancements in technology in the medical field.
• The South Korean Smart Pills Technology market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 84.05 million in 2024.
• The Australian Smart Pills Technology market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 43.70 million in 2024.
• The South East Asia Smart Pills Technology market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 57.99 million in 2024.
• The Rest of Asia Pacific Smart Pills Technology market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 59.67 million in 2024.

South America Smart Pills Technology Market Analysis

According to Cognitive Market Research, the global Smart Pills Technology market size was estimated at USD 3654.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 182.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Smart Pills Technology market size was valued at USD 78.20 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period due to elements including the development of new products that have been approved by regulators, a rise in the prevalence of colorectal cancer, and technical improvements in the healthcare industry.
• Argentina's Smart Pills Technology market had a market share of USD 30.70 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. The market for smart pill technology will continue to develop as a result of the increase in colorectal cancer cases and the regulatory acceptance of innovative products.
• Colombia Smart Pills Technology market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 16.26 million in 2024.
• Peru Smart Pills Technology market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 14.98 million in 2024.
• Chile Smart Pills Technology market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 13.16 million in 2024.
• The Rest of Latin America's Smart Pills Technology market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 29.42 million in 2024.

Middle East Smart Pills Technology Market Analysis

According to Cognitive Market Research, the global Smart Pills Technology market size was estimated at USD 3654.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 73.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031..

• The GCC Countries Smart Pills Technology market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 31.28 million in 2024. because of factors like increased colorectal cancer incidence, technological developments in the healthcare industry, and regulatory approval of new products.
• The Egypt Smart Pills Technology market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 7.67 million in 2024.
• The South Africa Smart Pills Technology market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 11.55 million in 2024 because of the advancements in technology within the healthcare industry.
• The Turkey Smart Pills Technology market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 6.29 million in 2024.
• The Nigeria Smart Pills Technology market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 7.67 million in 2024.
• The Rest of the MEA Smart Pills Technology market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 8.62 million in 2024.

Smart Pills Technology Market Analysis

How are Segments Performing in the Global Smart Pills Technology Market?

Smart Pills Technology Market Application Segment Analysis

According to Cognitive Market Research, capsule endoscopy category likely to dominate the Smart Pills Technology Market over the forecast period. With this technology, high-resolution images of the gastrointestinal tract are obtained by use of a tiny, ingestible capsule that is fitted with a little camera. Because capsule endoscopy is non-invasive and replaces traditional endoscopic procedures—which can be intrusive and painful for patients—it is in high demand.

The patient monitoring is the fastest-growing segment in the Smart Pills Technology Market. Owing to developments in wireless connectivity and sensor technology, smart pills may now gather data in real time on patient health factors like medication adherence, pH levels, and temperature. There is tremendous potential to improve healthcare outcomes by having the ability to continually and remotely monitor patients without interfering with their regular activities. Healthcare professionals can improve patient compliance, administer individualized therapies, and control diseases more effectively by utilizing data-driven insights.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Smart Pills Technology Industry. Request a Free Sample PDF!

Smart Pills Technology Market Target Area Segment Analysis

According to Cognitive Market Research, the small intestine segment holds the largest share of the market. This can be explained by the dramatic increase in diseases of the small intestine, such as small bowel malignancies, celiac disease, and Crohn's disease. Additionally, more people are suffering from short bowel syndrome, which will propel the market's expansion. Short bowel syndrome is an unusual malabsorption disease that results from an incompetent small intestine. The primary symptom, diarrhea, is associated with weight loss, dehydration, and malnourishment.

In the Smart Pills Technology Market, the esophagus category has been expanding at a rapid pace spurred by the growing need for non-invasive diagnostic instruments for esophageal disorders monitoring and treatment. Barrett's esophagus, esophageal cancer, and gastroesophageal reflux disease (GERD) can all be monitored in real time using smart pills thanks to their sophisticated sensors and imaging capabilities, which make them a less invasive option than traditional endoscopy. Smart pill usage in clinical settings has been aided by growing awareness of early detection and diagnosis, especially in esophageal cancer cases. Furthermore, the use of smart pills is related to increased patient comfort and technical improvements, which are driving market expansion in this category.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Smart Pills Technology Disease Indication Segment Analysis

Smart Pills Technology Market Disease indication Segment Analysis

According to Cognitive Market Research, the Barrett's Esophagus segment holds the largest market share because Barrett's Esophagus, a condition that can result in esophageal cancer, is a development of gastroesophageal reflux disease (GERD), which is becoming more common. Since non-invasive diagnostic methods, such as smart pills, provide a more practical and patient-friendly substitute for standard endoscopy in the monitoring and diagnosis of Barrett's esophagus, demand for them is growing. The need for early detection, ongoing monitoring, and better patient outcomes is driving the adoption of smart pill technology in this category, which is supporting the expansion of this market segment.

In the Smart Pills Technology market, the rapidly growing sector is the Small Bowel Diseases category because it might be difficult to diagnose diseases such as small intestine bacterial overgrowth (SIBO), celiac disease, and Crohn's disease. Many invasive procedures or imaging techniques used in traditional small bowel illness diagnosis approaches can be painful or produce insufficient results. As a more efficient diagnostic tool, smart tablets are becoming more and more popular because of their capacity to deliver real-time data on gastrointestinal parameters like motility and pH levels.

• Barrett'S Esophagus
• Small Bowel Diseases
• Colon Cancer
• Others

Smart Pills Technology End-use Segment Analysis

Smart Pills Technology Market End-use Segment Analysis

According to Cognitive Market Research, the hospitals and clinics segment dominates the market. The rising number of people suffering from inflammatory bowel disease (IBD) has made smart tablets a valuable diagnostic tool accepted by hospitals. Because they are non-invasive and have the potential to enhance early identification and diagnosis, smart tablets are a realistic option for hospitals seeking to enhance patient care and address the rising burden of IBD.

Diagnostic Centres are projected to be the fastest-growing segment in the Smart Pills Technology market, driven by the rising incidence of gastrointestinal illnesses and the growing need for sophisticated diagnostic solutions. Because they may provide comprehensive insights and real-time data, smart pills are becoming more and more popular among diagnostic facilities. These tablets provide non-invasive means for monitoring and diagnosing diseases related to the digestive tract. Improvements in smart pill technology, including clearer imaging, more accurate sensors, and more patient comfort, are contributing to the expanding use of these devices in diagnostic facilities.

• Hospitals and Clinics
• Diagnostic Centres
• Research Centres

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion